Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jan;64(1):77–82. doi: 10.1128/iai.64.1.77-82.1996

Resistance to Cryptococcus neoformans is associated with an inflammatory response to Toxoplasma gondii in the central nervous system of mice.

K M Aguirre 1, P C Sayles 1, G W Gibson 1, L L Johnson 1
PMCID: PMC173730  PMID: 8557377

Abstract

We have studied the resistance of Toxoplasma gondii-infected mice to subsequent infection with Cryptococcus neoformans. Mice infected with the moderately virulent ME49 strain of T. gondii are resistant to proliferation of yeast cells in their brains after intravenous inoculation of the serotype A C. neoformans strain 184. The resistance serves to limit proliferation of yeast cells that colonize the brain. Maximal levels of resistance correlate not with maximal systemic specific anti-Toxoplasma resistance but rather with high levels of inflammatory response, presumably to parasites released from cysts in the brain. Resistance is localized, as mice infected with ME49 show only limited resistance in their lungs after intratracheal instillation of yeast cells, but there is substantial protection against development of cerebral cryptococcosis.

Full Text

The Full Text of this article is available as a PDF (814.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguirre K., Havell E. A., Gibson G. W., Johnson L. L. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun. 1995 May;63(5):1725–1731. doi: 10.1128/iai.63.5.1725-1731.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Derouin F., Garin Y. J. Toxoplasma gondii: blood and tissue kinetics during acute and chronic infections in mice. Exp Parasitol. 1991 Nov;73(4):460–468. doi: 10.1016/0014-4894(91)90070-d. [DOI] [PubMed] [Google Scholar]
  3. Ferguson D. J., Hutchison W. M., Pettersen E. Tissue cyst rupture in mice chronically infected with Toxoplasma gondii. An immunocytochemical and ultrastructural study. Parasitol Res. 1989;75(8):599–603. doi: 10.1007/BF00930955. [DOI] [PubMed] [Google Scholar]
  4. Frenkel J. K., Caldwell S. A. Specific immunity and nonspecific resistance to infection: listeria, protozoa, and viruses in mice and hamsters,. J Infect Dis. 1975 Mar;131(3):201–209. doi: 10.1093/infdis/131.3.201. [DOI] [PubMed] [Google Scholar]
  5. Frenkel J. K., Escajadillo A. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am J Trop Med Hyg. 1987 May;36(3):517–522. doi: 10.4269/ajtmh.1987.36.517. [DOI] [PubMed] [Google Scholar]
  6. Gentry L. O., Remington J. S. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J Infect Dis. 1971 Jan;123(1):22–31. doi: 10.1093/infdis/123.1.22. [DOI] [PubMed] [Google Scholar]
  7. Harmsen A. G. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect Immun. 1988 Aug;56(8):1858–1863. doi: 10.1128/iai.56.8.1858-1863.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johnson L. L. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infect Immun. 1992 May;60(5):1979–1983. doi: 10.1128/iai.60.5.1979-1983.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Johnson L. L., Gibson G. W., Sayles P. C. Toxoplasma gondii: effect of sublethal irradiation on host resistance in mice. Exp Parasitol. 1995 Sep;81(2):172–181. doi: 10.1006/expr.1995.1106. [DOI] [PubMed] [Google Scholar]
  10. Lindberg R. E., Frenkel J. K. Toxoplasmosis in nude mice. J Parasitol. 1977 Apr;63(2):219–221. [PubMed] [Google Scholar]
  11. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy J. W., Cozad G. C. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun. 1972 Jun;5(6):896–901. doi: 10.1128/iai.5.6.896-901.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pfefferkorn E. R., Pfefferkorn L. C. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants. Exp Parasitol. 1976 Jun;39(3):365–376. doi: 10.1016/0014-4894(76)90040-0. [DOI] [PubMed] [Google Scholar]
  14. Spitzer E. D., Spitzer S. G., Freundlich L. F., Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet. 1993 Mar 6;341(8845):595–596. doi: 10.1016/0140-6736(93)90354-j. [DOI] [PubMed] [Google Scholar]
  15. Stefani M. M., Müller I., Louis J. Leishmania major infection in BALB/c mice: protection or exacerbation by treatment with different doses of BCG. Res Immunol. 1993 May;144(4):233–243. doi: 10.1016/0923-2494(93)80100-d. [DOI] [PubMed] [Google Scholar]
  16. Sumyuen M. H., Garin Y. J., Derouin F. Early kinetics of Toxoplasma gondii infection in mice infected orally with cysts of an avirulent strain. J Parasitol. 1995 Apr;81(2):327–329. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES